Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. The disease, characterized by constricted airways due to bronchitis and emphysema, is commonly seen in smokers but can also be brought on ...
Aug 23, 2013
0
0
Neutrophils are key players of the innate immune system that help fight off infection. These white blood cells attack in a number of ways: producing enzymes or toxic oxygen-containing molecules, ingesting pathogens, and releasing ...
Apr 17, 2017
0
17
A high level of cholesterol in the blood is associated with increased risk for cardiovascular disease. An LMU team has now identified an endogenous regulator of serum cholesterol – which could lead to new therapies for ...
Jan 17, 2014
0
0
Researchers have discovered how immune cells triggered by recurrent Strep A infections enter the brain, causing inflammation that may lead to autoimmune neuropsychiatric disorders in children. The study, performed in mice, ...
Dec 15, 2015
0
19
Environmental toxicants such as dioxins, PCBs, and pesticides can pose a risk for cardiovascular disease. For the first time a link has been demonstrated between atherosclerosis and levels of long-lived organic environmental ...
Oct 11, 2011
0
0
Cancer cells metastasize in several stages—first by invading surrounding tissue, then by infiltrating and spreading via the circulatory system. Some circulating cells work their way out of the vascular network, eventually ...
Sep 20, 2013
0
0
The Mount Sinai Medical Center is participating in the nationwide ABSORB III clinical trial testing the performance and potential clinical benefits of a fully dissolvable and temporary drug eluting stent to open heart artery ...
Sep 17, 2013
0
0
Cleveland Clinic researchers have discovered that a naturally occurring molecule may play a role in preventing plaque buildup inside arteries, possibly leading to new plaque-fighting drugs and improved screening of patients ...
Jul 11, 2012
0
2
Ongoing research at the Institute of Food Research, which is strategically funded by BBSRC, is exploring the use of virus-produced proteins that destroy bacterial cells to combat potentially dangerous microbial infections. ...
Aug 22, 2011
0
0
Pfizer will pay about $14 billion in cash for the cancer drug company Medivation, a deal that will add the pricey late-stage prostate cancer treatment Xtandi to its oncology portfolio.
Aug 22, 2016
0
1
